{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:55:27Z","timestamp":1790096127381,"version":"4.0.1"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1097\/pas.0b013e3181c89c98","type":"journal-article","created":{"date-parts":[[2010,1,21]],"date-time":"2010-01-21T02:06:05Z","timestamp":1264039565000},"page":"137-146","source":"Crossref","is-referenced-by-count":99,"title":["PAX2 Distinguishes Benign Mesonephric and Mullerian Glandular Lesions of the Cervix From Endocervical Adenocarcinoma, Including Minimal Deviation Adenocarcinoma"],"prefix":"10.1097","volume":"34","author":[{"given":"Joseph T.","family":"Rabban","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"McAlhany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melinda F.","family":"Lerwill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James P.","family":"Grenert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles J.","family":"Zaloudek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-1-20210131","first-page":"1059","article-title":"Mesonephric rest hyperplasia. A potential diagnostic pitfall","volume":"115","author":"Amin-Hanjani","year":"1991","journal-title":"Arch Pathol Lab Med"},{"key":"R2-1-20210131","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ygyno.2006.08.052","article-title":"Emerging roles for PAX8 in ovarian cancer and endosalpingeal development","volume":"104","author":"Bowen","year":"2007","journal-title":"Gynecol Oncol"},{"issue":"supp2","key":"R3-1-20210131","first-page":"191A","article-title":"Expression of PAX2 in endometrial hyperplasia and carcinomas: immunohistochemical analysis of 136 cases","volume":"20","author":"Cao","year":"2007","journal-title":"Mod Pathol"},{"key":"R4-1-20210131","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1053\/hupa.2001.22753","article-title":"Pax-2 expression in adult renal tumors","volume":"32","author":"Daniel","year":"2001","journal-title":"Hum Pathol"},{"key":"R5-1-20210131","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1073\/pnas.89.4.1179","article-title":"Pax-2 is a DNA-binding protein expressed in embryonic kidney and Wilms tumor","volume":"89","author":"Dressler","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"R6-1-20210131","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1097\/00000478-199012000-00002","article-title":"Mesonephric remnants, hyperplasia, and neoplasia in the uterine cervix. A study of 49 cases","volume":"14","author":"Ferry","year":"1990","journal-title":"Am J Surg Pathol"},{"key":"R7-1-20210131","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1089\/dna.1993.12.381","article-title":"Murine Pax-2 protein is a sequence-specific trans-activator with expression in the genital system","volume":"12","author":"Fickenscher","year":"1993","journal-title":"DNA Cell Biol"},{"key":"R8-1-20210131","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1097\/00000478-198909000-00001","article-title":"Adenoma malignum (minimal deviation adenocarcinoma) of the uterine cervix. A clinicopathological and immunohistochemical analysis of 26 cases","volume":"13","author":"Gilks","year":"1989","journal-title":"Am J Surg Pathol"},{"key":"R9-1-20210131","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/0092-8674(92)90281-G","article-title":"Pax in development","volume":"69","author":"Gruss","year":"1992","journal-title":"Cell"},{"key":"R10-1-20210131","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1006\/gyno.1993.1083","article-title":"Mesonephric remnant hyperplasia of the cervix: a clinicopathologic analysis of 14 cases","volume":"49","author":"Jones","year":"1993","journal-title":"Gynecol Oncol"},{"key":"R11-1-20210131","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bcp.2006.06.024","article-title":"PAX genes: roles in development, pathophysiology, and cancer","volume":"73","author":"Lang","year":"2007","journal-title":"Biochem Pharmacol"},{"key":"R12-1-20210131","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1046\/j.1365-2559.2003.01684.x","article-title":"CD10 and calretinin staining of endocervical glandular lesions, endocervical stroma and endometrioid adenocarcinomas of the uterine corpus: CD10 positivity is characteristic of, but not specific for, mesonephric lesions and is not specific for endometrial stroma","volume":"43","author":"McCluggage","year":"2003","journal-title":"Histopathology"},{"key":"R13-1-20210131","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1097\/PAS.0b013e31816d71ad","article-title":"Expression of pax8 as a useful marker in distinguishing ovarian carcinomas from mammary carcinomas","volume":"32","author":"Nonaka","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"R14-1-20210131","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1097\/00000478-200112000-00011","article-title":"Mesonephric adenocarcinoma of the uterine corpus: CD10 expression as evidence of mesonephric differentiation","volume":"25","author":"Ordi","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"R15-1-20210131","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1097\/00000478-200302000-00005","article-title":"CD10 expression in epithelial tissues and tumors of the gynecologic tract: a useful marker in the diagnosis of mesonephric, trophoblastic, and clear cell tumors","volume":"27","author":"Ordi","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"R16-1-20210131","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/00004347-199510000-00002","article-title":"Mesonephric hyperplasia of the uterine cervix: a clinicopathologic study of 51 cases","volume":"14","author":"Seidman","year":"1995","journal-title":"Int J Gynecol Pathol"},{"key":"R17-1-20210131","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/00000478-200103000-00013","article-title":"Mesonephric adenocarcinomas of the uterine cervix: a study of 11 cases with immunohistochemical findings","volume":"25","author":"Silver","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"R18-1-20210131","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1002\/1097-0142(19860901)58:5<1131::AID-CNCR2820580526>3.0.CO;2-0","article-title":"Minimal deviation adenocarcinoma of the uterine cervix (\u201cadenoma malignum\u201d). An immunohistochemical comparison with microglandular endocervical hyperplasia and conventional endocervical adenocarcinoma","volume":"58","author":"Steeper","year":"1986","journal-title":"Cancer"},{"key":"R19-1-20210131","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/00004347-199907000-00005","article-title":"Infrequent occurrence of high-risk human papillomavirus and of p53 mutation in minimal deviation adenocarcinoma of the cervix","volume":"18","author":"Toki","year":"1999","journal-title":"Int J Gynecol Pathol"},{"key":"R20-1-20210131","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/modpathol.3800535","article-title":"PAX2: a reliable marker for nephrogenic adenoma","volume":"19","author":"Tong","year":"2006","journal-title":"Mod Pathol"},{"key":"R21-1-20210131","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/modpathol.3800827","article-title":"Expression of PAX2 in papillary serous carcinoma of the ovary: immunohistochemical evidence of fallopian tube or secondary Mullerian system origin?","volume":"20","author":"Tong","year":"2007","journal-title":"Mod Pathol"},{"key":"R22-1-20210131","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.1242\/dev.121.12.4057","article-title":"Pax-2 controls multiple steps of urogenital development","volume":"121","author":"Torres","year":"1995","journal-title":"Development"},{"key":"R23-1-20210131","first-page":"925(A)","article-title":"Staining for p16 of cervical mesonephric remnants and hyperplasia: a potential diagnostic pitfall","volume":"19","author":"Truskinovksy","year":"2006","journal-title":"Mod Pathol"},{"key":"R24-1-20210131","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/nature04225","article-title":"Hypomethylation-linked activation of PAX2 mediates tamoxifen-stimulated endometrial carcinogenesis","volume":"438","author":"Wu","year":"2005","journal-title":"Nature"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/PAS.0b013e3181c89c98","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:12:48Z","timestamp":1786039968000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000478-201002000-00001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0b013e3181c89c98","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]}}}